AboutCivica Civicais a 501(c)(4) social welfare organization established in 2018 by healthsystems and philanthropies to reduce chronic generic drug shortages and relatedhigh prices in the United States. Civica is led by an experienced team ofhealthcare and pharmaceutical industry leaders.
Today,more than 55 health systems have joined Civica. They represent over 1,500hospitals and one-third of all U.S. hospital beds. Civica has also begun tosupply the U.S. Department of Veteran's Affairs, the U.S. Department of Defenseand the U.S. Strategic National Stockpile of essential medicines.
Civicarecently announced plans to expand its mission, via a unit called CivicaScript,to into the outpatient pharmacy space and to manufacture and distributeinsulins that, once approved, will be available to people with diabetes atsignificantly lower prices than insulins currently on the market. Theavailability of Civica's affordable insulins, beginning in 2024, will benefitpeople with diabetes who have been forced to choose between life sustainingmedicines and living expenses, particularly those uninsured or underinsured whooften pay the most out of pocket for their medications.
Civica'smission is to ensure that quality generic medications are accessible andaffordable to everyone. Since established, the #1 Policy for the Civica teamhas been "Do What Is in the Best Interest of Patients." Civica'smanufacturing facility in Petersburg, Virginia, is the future home ofaffordable insulin and essential sterile injectable medicines. The facility iscurrently in late-stage construction and hiring for the site is well-underway.
To findout more about how Civica's innovative model is directly impacting patientcare, click here to read a summary from the NewEngland Journal of Medicine. () To learnmore about Civica's plans to bring affordable insulin to Americans living withdiabetes, click here to read an article in BioSpace.
Job Description The QA Operations Specialist will join the Civica, Inc. ("Civica") organization and its newly forming team at the Petersburg, Virginia site by bringing their knowledge and experience in service to patients and pursuit of excellence in quality and compliance. The Petersburg site serves as Civica's new fill finish facility dedicated to the manufacture and supply of essential generic sterile injectable medications.
The role is essential to assure the Petersburg site's manufacturing and operations activities comply with applicable regulatory standards (e.g., Current Good Manufacturing Practices, Good Distribution Practices) and expectations for the development and reliable supply of quality medicines.
Responsibilities of this position include, but are not limited to, Quality Operations review and approval of materials, bill of materials, batch records and GMP documentation to support the design, implementation, and maintenance of manufacturing processes that meets or exceed FDA requirements.
Essential Duties and Responsibilities: Support operational compliance aspects of sterile fill-finish manufacturing of products including but not limited to material, bill of material and executed batch record review and approval. Partner with operations to develop manufacturing batch records to be compliant with regulatory and company requirements. Working cross-functionally to determine defect criticality, inspection methods, and training plans for both QA Operations and Manufacturing employees. Provide cross-functional support to MSAT and Operations in establishing process limits for manufacturing processes such as filling and packaging. Act as a resource for colleagues. Lead or participate in Quality Risk Management Processes as needed. Promote a safety and quality-first mindset in daily job functions. Consistently represent the Quality Unit as a proactive and GxP-compliant team player when working with Operations in daily job duties. Ensure that all aspects of the handling, and manufacturing of pharmaceutical products at the site comply with Civica and relevant FDA and Drug Enforcement Administration (DEA) regulatory requirements. Support material receipt, quality control, chain of custody, disposition, and release of materials within the Enterprise Resource Planning system. Maintain current knowledge of FDA and Civica requirements to keep pace with evolving requirements for manufacturing. Support, lead, or approve documents, change controls, investigations and CAPAs to support Civica's Quality Management System. Proactively identify and work collaboratively to resolve problems by taking risk-based and compliant approaches to solutions. Proactively be a team lead for department objectives with a minimal amount of supervision. Includes complex project management that may overlap with other functional areas. Support site objectives with a minimal amount of supervision. Includes simple project management that may involve other functional areas. Basic Qualifications and Capabilities: Bachelor's degree with 4+ years of experience in a QA role in a cGMP production environment. Associate degree with 6+ years of experience in a QA role in a cGMP production environment may be considered. Ability to apply technical expertise to solve problems and issues. Participating in and leading activities that support regulatory agency inspections is required. Project management, organization, and execution skills are required. Excellent interpersonal and written communication skills and experience using various software/electronic applications required. Self-motivated, flexible, and able to work in a small, fast-paced, dynamic, environment. Ability to work autonomously and within established guidelines, procedures, and practices. Committed to delivering high-quality results, working with others to overcome challenges, and focusing on what matters. Continuously looking for opportunities to learn, build skills, and share knowledge with others. Preferred Qualifications: Manufacturing Batch Record Design experience is highly desirable. Technical expertise in sterile pharmaceutical isolator technology, combination products and medical devices is highly desirable. Experience in Drug Enforcement Agency requirements for the handling and distribution of controlled substances is desired.
